Selection of high efficient transdermal lipid vesicle for curcumin skin delivery

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 302-309

  Zhao, Ying Zheng ^a   Lu, Cui Tao ^a   Zhang, Yi ^a   Xiao, Jian ^a   Zhao, Ya Ping ^a   Tian, Ji Lai ^b   Xu, Yan Yan ^c   Feng, Zhi Guo ^a   Xu, Chong Yong ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c LISHUI CENTRAL HOSPITAL   (China)

Author keywords

Anti inflammatory effect; Curcumin; Encapsulation efficiency; Transdermal vector

Indexed keywords

CARRAGEENAN; CURCUMIN; LIPOSOME; PROPYLENE GLYCOL;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RELEASE; FEMALE; IN VITRO STUDY; LIPID VESICLE; MALE; MICROENCAPSULATION; MICROMORPHOLOGY; NONHUMAN; PARTICLE SIZE; PAW EDEMA; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE;

EID: 84884149634     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.052     Document Type: Article

References (31)

1. Ainbinder, D., Paolino, D., Fresta, M., Touitou, E., 2010. Drug delivery applications with ethosomes. J. Biomed. Nanotechnol. 6, 558-568.
2. Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., 2007. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807-818.
3. Anitha, P., Ramkanth, S., Saleem, M.T., Umasankari, K., Reddy, B.P., Chetty, M., 2011. Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: A combinational approach. Pak. J. Pharm. Sci. 24, 155-163.
4. Béranger, F., Crozet, C., Goldsborough, A., Lehmann, S., 2008. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage. Biochem. Biophys. Res. Commun. 334, 44-48.
5. Branca, C., Maccarrone, S., Magazú, S., Maisano, G., Bennington, S.M., Taylor, J., 2005. Tetrahedral order in homologous disaccharide-water mixtures. J. Chem. Phys. 22, 174513.
6. Duangjit, S., Opanasopit, P., Rojanarata, T., Ngawhirunpat, T., 2011. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J. Drug. Deliv. 2011, 418316.
7. Dubey, V., Mishra, D., Dutta, T., Nahar, M., Saraf, D.K., Jain, N.K., 2007. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control. Release 123, 148-154. (Pubitemid 47562141)
8. Elsayed, M.M., Abdallah, O.Y., Naggar, V.F., Khalafallah, N.M., 2007. Lipid vesicles forskin delivery of drugs: reviewing three decades of research. Int. J. Pharm. 332, 1-16. (Pubitemid 46237706)
9. Godin, B., Touitou, E., 2004. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. Release 94, 365-379. (Pubitemid 38117147)
10. Goffin, V., Henry, F., Pierard-Franchimont, C., Pierard, G.E., 2000. Penetration enhancers assessed by corneoxenometry. Skin. Pharmacol. Appl. Skin. Physiol. 13, 280-284. (Pubitemid 30666026)
11. Izutsu, K., Yomota, C., Kawanishi, T., 2011. Stabilization of liposomes in frozen solutions through control of osmotic flow and internal solution freezing by trehalose. J. Pharm. Sci. 100, 2935-2944.
12. Kircik, L., Friedman, A., 2010. Optimizing acne therapy with unique vehicles. J. Drugs Dermatol. 9, 53-57.
13. Liu, D., Ge, Y., Tang, Y., Yuan, Y., Zhang, Q., Li, R., Xu, Q., 2010. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies. J. Microencapsul. 27, 726-734.
14. Manconi, M., Sinico, C., Caddeo, C., Vila, A.O., Valenti, D., Fadda, A.M., 2011. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int. J. Pharm. 412, 37-46.
15. Manconi, M., Sinico, C., Valenti, D., Lai, F., Fadda, A.M., 2006. Niosomes as carriers for tretinoin III: a study into the ex vivo cutaneous delivery of vesicle-incorporated tretinoin. Int. J. Pharm. 311, 11-19.
16. Milewski, M., Stinchcomb, A.L., 2011. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride. Pharm. Res. 28, 124-134.
17. Mourtas, S., Canovi, M., Zona, C., Aurilia, D., Niarakis, A., La Ferla, B., Salmona, M., Nicotra, F., Gobbi, M., Antimisiaris, S.G., 2011. Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide. Biomaterials 32, 1635-1645.
18. Nagle, A., Goyal, A.K., Kesarla, R., Murthy, R.R., 2011. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model. J. Liposome Res. 21, 134-140.
19. Paolino, D., Lucania, G., Mardente, D., Alhaique, F., Fresta, M., 2005. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control. Release 106, 99-110. (Pubitemid 41140085)
20. Pierre, M.B., Dos Santos Miranda Costa, I., 2011. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch. Dermatol. Res. 303, 607-621.
21. Sadeghi, H., Hajhashemi, V., Minaiyan, M., Movahedian, A., Talebi, A., 2011. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw oedema in rats. Eur. J. Pharmacol. 667, 396-401.
22. Samad, A., Ullah, Z., Alam, M.I., Wais, M., Shams, M.S., 2009. Transdermal drug delivery system: patent reviews. Recent Pat. Drug Deliv. Formul. 3, 143-152.
23. Schäfer-Korting, M., Korting, H.C., Ponce-Pöschl, E., 1994. Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Investig. 72, 1086-1091.
24. Schroeter, A., Engelbrecht, T., Neubert, R.H., Goebel, A.S., 2010. New nanosized technologies for dermal and transdermal drug delivery. A review. J. Biomed. Nanotechnol. 6, 511-528.
25. Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H.G., 2010. Novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18, 1606-1614.
26. Tanaka, M., Michida, Y., Niu, S., Ikeda, T., Jana, N.R., Doi, H., Kurosawa, M., Nekooki, M., Nukina, N., 2004. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington's disease. Nat. Med. 10, 148-154. (Pubitemid 38524884)
27. Touitou, E., Dayan, N., Bergelson, L., Godin, B., Eliaz, M., 2000. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 65, 403-418. (Pubitemid 30122942)
28. Touitou, E., Godin, B., Dayan, N., Weiss, C., Piliponsky, A., Levi-Schaffer, F., 2001. Intracellular delivery mediated by an ethosomal carrier. Biomate 22, 3053-3059.
29. Wang, L.Q., Zhang, J., Cai, L.L., Wen, J., Shi, H.S., Li, D.N., Guo, F.C., Wang, Y.S., 2012. Liposomal curcumin inhibits Lewis lung cancer growth primarily through inhibition of angiogenesis. Oncol. Lett. 4, 107-112.
30. Xu, H., Sun, Y., Shao, J., Xiong, L., Huang, C., 2007. Study on preparation of curcumin lipsomes and the chemicophysical propery. Chin. Hosp. Pharm. J. 27, 1363-1365.
31. Yu, M., Jiang, F., Ding, Z., 2009. Advances in studies on curcumin. Chin. Trad. Herbal Drugs 5, 828-831